TrialAlimentary pharmacology & therapeutics2019

Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT.

Siddharth Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.